INDIVIDUAL ARTICLE: Ruxolitinib 1.5% Cream and the “Boxed Warning Paradox”: Reappraisal of Safety Through the Lens of Pharmacokinetics

Insights Into Demographics, Comorbidities, and Risk Factors in Keloids and Hypertrophic Scars: A Retrospective Study Blog Post

Evaluating Quality and Reliability of Most-Viewed TikTok Videos About Spironolactone Blog Post

Evaluating Quality and Reliability of Most-Viewed TikTok Videos About Spironolactone

Use of Upadacitinib in Refractory Behcet’s Disease: Case Report and Systematic Literature Review

JDD Year In Review – Part 1 Blog Post

Expert Roundtable on Skin Care Integration After Aesthetic Procedures: Consensus Recommendations

Vessel-Targeting Therapies for the Management of Rosacea: A Review of Current Evidence

Pharmacological Complications in Ocular Dermatology: A Review and Update

International Dermatology Outcome Measures (IDEOM): A Report From the 2023 Annual Meeting

Last Chance for CME – Prevention is the Best Medicine: ADing up the Data Blog Post

INDIVIDUAL ARTICLE: USCOM IV Algorithm for the Prevention and Management of Targeted Therapy-Related Cutaneous Adverse Events